This is a community-generated profile. If you would like to claim it, please .
Second Genome Funding
$0
33 rounds
Second Genome is active in the following markets / industries: biotechnology. The company has secured funding across 3 rounds and is valued at $0. Their most recent funding was raised on April 20, 2016.
Funding Rounds
B
$42600000Series BApr 2016
+2
U
$2500000A
$5000000Investors of Second Genome
Angel
Sander Duncan
Healthcare-focused, early-stage investor focused on software-driven companies in the care delivery and drug development spaces.
justin kuczynski
hi there
Matthew Winkler
Went to University of Victoria
LifeForce Capital
Sr One
Drew Taylor
Digitalis is a venture capital firm that invests in fundamental new ideas in math and science to address complex health problems.
Mayo Clinic
Rounds
B
Roche Venture Fund
Rounds
B